Gyre Therapeutics GYRE
NASDAQ GYRE
$4.23 -0.42 (-9.03%)
At close: Nov 10, 2026 · 4:00 PM EST

Gyre Therapeutics (GYRE) Dividends payables (2022)

Updated

Gyre Therapeutics' Dividends payables was $7.56 million in Q4 2022.

Analysis

Gyre Therapeutics (GYRE) Dividends payables (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.13 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Gyre Therapeutics 487.81 Mn 295.13 Mn 30.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 7.56 Mn
API Access

Gyre Therapeutics Dividends payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-payables&ticker=GYRE&period=max&api_key=YOUR_API_KEY